Histamine and schizophrenia

被引:34
|
作者
Arrang, Jean-Michel [1 ]
机构
[1] INSERM, U573, Unite Neurobiol & Pharmacol Mol, Ctr Paul Broca, F-75014 Paris, France
来源
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA | 2007年 / 78卷
关键词
D O I
10.1016/S0074-7742(06)78009-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
With the availability of an increased number of experimental tools, for example potent and brain-penetrating H-1-, H-2-, and H-3-receptor ligands and mutant mice lacking the histamine synthesis enzyme or the histamine receptors, the functional roles of histaminergic neurons in the brain have been considerably clarified during the recent years, particularly their major role in the control of arousal, cognition, and energy balance. Various approaches tend to establish the implication of histaminergic neurons in schizophrenia. A strong hyperactivity of histamine neurons is induced in rodent brain by administration of methamphetamine or NMDA-receptor antagonists. Histamine neuron activity is modulated by typical and atypical neuroleptics. H-3-receptor antagonists/ inverse agonists display antipsychotic-like properties in animal models of the disease. Because of the limited predictability value of most animal models and the paucity of drugs affecting histaminergic transmission that were tried so far in human, the evidence remains therefore largely indirect, but supports a role of histamine neurons in schizophrenia.
引用
收藏
页码:247 / +
页数:42
相关论文
共 50 条
  • [31] Histamine H2 receptor deficit in glutamatergic neurons contributes to the pathogenesis of schizophrenia
    Ma, Qianyi
    Jiang, Lei
    Chen, Han
    An, Dadao
    Ping, Yiting
    Wang, Yujia
    Dai, Haibin
    Zhang, Xiangnan
    Wang, Yi
    Chen, Zhong
    Hu, Weiwei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (09)
  • [32] Histamine H-2 receptor antagonists in schizophrenia - Rationale for use and therapeutic potential
    Deutsch, SI
    Rosse, RB
    Schwartz, BL
    CNS DRUGS, 1997, 8 (04) : 276 - 284
  • [33] Relative quantification analysis of cortical histamine 1 and muscarinic 1 receptor expression in patients with schizophrenia
    Mancama, DT
    Preece, P
    Landau, S
    Arranz, MJ
    Kerwin, RW
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 623 - 623
  • [34] Histamine and histamine intolerance
    Maintz, Laura
    Novak, Natalija
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (05) : 1185 - 1196
  • [35] Histamine H2 receptor deletion in glutamatergic neurons causes schizophrenia-like phenotypes
    JIANG Lei
    MA Qian-yi
    CHEN Zhong
    HU Wei-wei
    中国药理学与毒理学杂志, 2021, 35 (09) : 688 - 688
  • [36] Reversal of Oxidative Stress by Histamine H3 Receptor-Ligands in Experimental Models of Schizophrenia
    Mahmood, D.
    Khanam, R.
    Pillai, K. K.
    Akhtar, M.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (05): : 222 - 229
  • [37] Chromosomal mapping, mutation screening and association analysis of the histamine 3 receptor in clozapine treated people with schizophrenia
    Mancama, DT
    Munro, J
    Osborne, S
    Arranz, MJ
    Makoff, A
    Kerwin, RW
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 74 - 74
  • [38] Histamine, histamine intoxication and intolerance
    Kovacova-Hanuskova, E.
    Buday, T.
    Gavliakova, S.
    Plevkova, J.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (05) : 498 - 506
  • [39] HISTAMINE RELEASERS AND HISTAMINE SENSITIVITY
    GUTH, PS
    BYRON, JW
    AMBRUS, JL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1961, 13 (04) : 254 - &
  • [40] STUDIES ON HISTAMINE AND HISTAMINE ANTAGONISTS
    SERAFINI, U
    JOURNAL OF ALLERGY, 1948, 19 (04): : 256 - 270